openPR Logo
Press release

Biosimulation Market Status and Outlook to 2025 - Dassault Systèmes, Rosa, LLC, Genedata AG, Leadscope, Evidera, Advanced Chemistry Development

02-18-2019 05:26 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

"Global Biosimulation Market Analysis to 2025" is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global biosimulation market with detailed market segmentation by product, application, end user, and geography.

Biosimulation Market to 2025 - Global Analysis and Forecasts by Product (Software and Services), Application (Drug Discovery, Drug Development and Others); and By End User (Pharmaceutical & Biotechnology Companies, Academic Research Institutions and Others)

The growth of the biosimulation technology can be attributed to the increasing focuses on advanced drugs development. Additionally, the increasing healthcare spending and improved simulation techniques are also helps to upsurge the growth of the market. Moreover, the increased accuracy of prediction before an actual trial and increasing healthcare expenditure along with technological advancements are likely to add novel opportunities for the global biosimulation market in the forecast period.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100001203

Biosimulation is a mathematical simulation of biological process in which computer aided programs are used for the simulation of biological processes and systems. It is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.

List of Companies mentioned in this report are-
1. Simulations Plus
2. Certara USA, Inc.
3. Schrödinger, LLC
4. Dassault Systèmes
5. Rosa & Co., LLC
6. Genedata AG
7. Leadscope, Inc.
8. Evidera
9. Advanced Chemistry Development

North America followed by Europe, is expected to dominate the biosimulation market in the global arena due to the increasing growth in pharmaceutical and biotechnology industry and the growing adoption of biosimulation software by regulatory bodies in the region. The Asia-Pacific region anticipated to show a significant growth rate due to the increasing demand for advanced computer technologies in the biosimulation market over the next five years.

Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPHE100001203

On the basis of product the market is segmented into software and services. The application market is segmented into drug discovery, drug development and others. Based on the end user, the market is classified as pharmaceutical & biotechnology companies, academic research institutions and others.

The report provides a detailed overview on the industry overview and forecast of the global biosimulation based on product, application and end user. It also provides market size and forecast till 2025 for overall Biosimulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Buy this Report at https://www.theinsightpartners.com/buy/TIPHE100001203

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market Status and Outlook to 2025 - Dassault Systèmes, Rosa, LLC, Genedata AG, Leadscope, Evidera, Advanced Chemistry Development here

News-ID: 1594058 • Views:

More Releases from The Insight Partners

Basal Insulin Market Evolves: Biosimilars, Smart Delivery Drive Diabetes Care Advances
Basal Insulin Market Evolves: Biosimilars, Smart Delivery Drive Diabetes Care Ad …
The basal insulin market continues to evolve rapidly, driven by rising diabetes prevalence worldwide and innovative solutions for better glucose control. Leading products like Lantus, Levemir, and Toujeo address needs across Type I Diabetes, Type II Diabetes, Gestational Diabetes, and Prediabetes in hospitals and clinics. This press release explores key growth drivers, trends, and opportunities shaping the future of basal insulin therapies. The Basal Insulin Market is expected to register a
Balustrade Market Expansion Fueled by Urbanization, Safety Standards, and Innovative Designs
Balustrade Market Expansion Fueled by Urbanization, Safety Standards, and Innova …
The balustrade market thrives amid surging global construction and a shift toward aesthetic, secure architectural solutions. Industry leaders highlight how urbanization drives demand for balustrades in residential, commercial, and public projects worldwide. The Balustrade Market is expected to register a CAGR of 5% from 2025 to 2031. Download PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00020575/?utm_source=OpenPR&utm_medium=10813 Growth Drivers Rapid urbanization spurs construction of high-rise buildings, apartments, and infrastructure, necessitating balustrades for staircases, balconies, and walkways to ensure
Ash Handling System Market Witnesses Robust Expansion Driven by Industrialization and Sustainability Focus
Ash Handling System Market Witnesses Robust Expansion Driven by Industrializatio …
The Ash Handling System Market continues to surge forward, propelled by rapid industrialization and heightened environmental awareness across power generation, steel, and waste management sectors. Advanced systems for managing ash from industrial processes are gaining traction as industries prioritize efficient waste handling and regulatory compliance. This growth underscores the sector's pivot toward sustainable operations without compromising productivity. The Ash Handling System Market is expected to register a CAGR of 5.6% from
Airport IT Systems Market Advances with Smart Technologies and Operational Efficiency
Airport IT Systems Market Advances with Smart Technologies and Operational Effic …
The Airport IT Systems Market continues to evolve rapidly, fueled by the integration of advanced digitalization, IoT, and cloud-based solutions that enhance airport operations and passenger experiences worldwide. Key segments such as Airport Operational Control Centers (AOCC) and Departure Control Systems (DCS) play pivotal roles in streamlining processes for civil and commercial airports, addressing rising air traffic demands through smarter, more connected infrastructures. Leading providers like Amadeus IT Group, IBM,

All 5 Releases


More Releases for Biosimulation

Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Biosimulation Market Through 2025? The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Biosimulation Market Size and Projected Growth Rate? The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market? The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry. Global Biosimulation Market: Driven factors and Restrictions factors The research
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766 This latest report researches the industry structure, sales, revenue,